| Literature DB >> 34711458 |
Edwin Nieblas-Bedolla1, Jeffrey Zuccato2, Harriet Kluger3, Gelareh Zadeh4, Priscilla K Brastianos5.
Abstract
The proportion of patients developing central nervous system (CNS) metastasis is increasing. Most are identified once symptomatic. Surgical resection is indicated for solitary or symptomatic brain metastases, separation surgery for compressive radioresistant spinal metastases, and instrumentation for unstable spinal lesions. Surgical biopsies are performed when histological diagnoses are required. Stereotactic radiosurgery is an option for limited small brain metastases and radioresistant spinal metastases. Whole-brain radiotherapy is reserved for extensive brain metastases and leptomeningeal disease with approaches to reduce cognitive side effects. Radiosensitive and inoperable spinal metastases typically receive external beam radiotherapy. Systemic therapy is increasingly being utilized for CNS metastases.Entities:
Keywords: Brain metastases; Central nervous system; Spinal metastases; Systemic cancer
Mesh:
Year: 2021 PMID: 34711458 DOI: 10.1016/j.hoc.2021.08.004
Source DB: PubMed Journal: Hematol Oncol Clin North Am ISSN: 0889-8588 Impact factor: 3.722